Assessment of cardiovascular disease risk using immunosensors for determination of C-reactive protein levels in serum and saliva: A pilot study

Bioanalysis

Volumn 6, Issue 11, 2014, Pages 1459-1470

  Justino, Celine I ^a   Duarte, Kátia ^a   Lucas, Susana ^b   Chaves, Paulo ^c   Bettencourt, Paulo ^c   Freitas, Ana Cristina ^a,b   Pereira, Ruth ^c,d   Cardoso, Susana ^e   Duarte, Armando C ^a   Rocha Santos, Teresa A ^a,b  

^a UNIVERSITY OF AVEIRO   (Portugal)

^b INSTITUTO PIAGET   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d UNIVERSITY OF PORTO   (Portugal)

^e INESC   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; SINGLE WALLED NANOTUBE;

ADULT; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIELD EFFECT TRANSISTOR; HUMAN; IMMUNOSENSOR; LIMIT OF DETECTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PILOT STUDY; PROTEIN DETERMINATION; RISK ASSESSMENT; RISK FACTOR; SALIVA LEVEL; VALIDATION PROCESS; CARDIOVASCULAR DISEASES; IMMUNOLOGICAL PROCEDURES; IMMUNOLOGY; METABOLISM; PROCEDURES;

C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; IMMUNOLOGIC TESTS; MALE; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS;

EID: 84904603551     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.14.12     Document Type: Article

References (32)

1. Adams JE. Clinical integration of C-reactive protein for primary and secondary risk factor stratification. In:Markers in Cardiology:A Case-Oriented Approach. Adams JE, Apple J, Jaffe AS (Eds). Blackwell Publishing Ltd, Oxford, UK (2008).
2. PNHP. Portuguese National Health Plan 2012-2016. Ministry of Health, Lisbon, Portugal (2012).
3. Nichols M, Townsend N, Scarborough P, et al. European Cardiovascular Disease Statistics. European Heart Network, Brussels, Belgium (2012).
4. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update. A report from the American Heart Association. Circulation 125, 2-220 (2012).
5. Packard RRS, Libby P. Inflammation in atherosclerosis:from vascular biology to biomarker discovery and risk prediction. Clin. Chem. 54(1) 24-38 (2008).
6. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin. Chem. 43(1), 52-58 (1997).
7. Smith CJ, Emsley HCA, Gavin CM, et al. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischaemic stroke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 4(2), 1-8 (2004).
8. Mitaka C. Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome. Clin. Chim. Acta 351(1-2), 17-29 (2005).
9. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 107(3), 363-369 (2003).
10. Qureshi A, Niazi JH, Kallempudi S, et al. Label-free capacitive biosensor for sensitive detection of multiple biomarkers using gold interdigitated capacitor arrays. Biosens. Bioelectron. 25(10), 2318-2323 (2010).
11. Justino CIL, Freitas AC, Amaral JP, et al. Disposable immunosensors for C-reactive protein based on carbon nanotubes field effect transistors. Talanta 108, 165-170 (2013).
12. Pfaffe T, Cooper-White J, Beyerlein P, et al. Diagnostic potential of saliva:current state and future applications. Clin. Chem. 57(5), 675-687 (2011).
13. Ovchinnikov DA, Cooper MA, Pandit P, et al. Tumoursuppressor gene promoter hypermethylation in saliva of head and neck cancer patients. Transl. Oncol. 5(5), 321-326 (2012).
14. Foley JD, Sneed JD, Steinhubl SR, et al. Oral fluids that detect cardiovascular disease biomarkers. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 114(2), 207-214 (2012).
15. Foo JYY, Wan Y, Kostner K, et al. NT-ProBNP levels in saliva and its clinical relevance to heart failure. PLoS ONE 7(10), e48452 (2012).
16. Friedewald WT, Levy RT, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18(6), 499-502 (1972).
17. Justino CIL, Rocha-Santos TAP, Amaral JP, et al. Effects of geometry parameters of NTFET devices on the I-V measurements. Solid State Electron. 81, 32-34 (2013).
18. Human C-Reactive Protein (CRP) ELISA Kit, Technical Bulletin. www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Bulletin/1/rab0096bul. pdf
19. Testing protocol, Cat. # 1-3302, SalimetricsTM. www.salimetrics.com/ documents/1-3302.pdf
20. SigmaPlot 11.0 (Statistical Analysis Software), Systat Software Inc., Germany, 2008.
21. Miller JN, Miller JC. Statistics and Chemometrics for Analytical Chemistry (5th Edition). Pearson Prentice Hall, NY, USA (2005).
22. Bini A, Centi S, Tombelli S, et al. Development of an optical RNA-based aptasensor for C-reactive protein. Anal. Bioanal. Chem. 390(4), 1077-1086 (2008).
23. Yang Y-N, Lin H-I, Wang J-H, et al. An integrated microfluidic system for C-reactive protein measurement. Biosens. Bioelectron. 24(10), 3091-3096 (2009).
24. Meyer MHF, Hartmann M, Krause HJ, et al. CRP determination based on a novel magnetic biosensor. Biosens. Bioelectron. 22(6), 973-979 (2007).
25. Ouellet-Morin I, Danese A, Williams B, et al. Validation of a high-sensitivity assay for C-reactive protein in human saliva. Brain Behav. Immun. 25(4), 640-646 (2011).
26. Kaufman E, Lamster IB. The diagnostic applications of saliva-a review. Crit. Rev. Oral Biol. Med. 13(2), 197-202 (2002).
27. Giannobile W, Beikler T, Kinney JS, et al. Saliva as a diagnostic tool for periodontal disease:current state and future directions. Periodontol. 2000 50(1), 52-64 (2009).
28. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease:application to clinical and public health practice:a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 107, 499-511 (2003).
29. Punyadeera C, Dimeski G, Kostner K, et al. One-step homogeneous C-reactive protein assay for saliva. J. Immunol. Methods 373(1-3), 19-25 (2011).
30. Dillon MC, Opris DC, Kopanczyk R, et al. Detection of homocysteine and C-reactive protein in the saliva of healthy adults:comparison with blood levels. Biomark. Insights 2010(5), 57-61 (2010).
31. Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM 8(1), 19-20 (2006).
32. Out D, Hall RJ, Granger DA, et al. Assessing salivary C-reactive protein:longitudinal associations with systemic inflammation and cardiovascular disease risk in women exposed to intimate partner violence. Brain Behav. Immun. 26(4), 543-551 (2012).